Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
YARW compared with VYNE: revenue, margins and what each company keeps, and the suppliers and customers both name
YARW
Yarrow Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
VYNE
VYNE Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
YARW
Yarrow Bioscience, Inc.
vs
VYNE
VYNE Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only YARW
2
—
Tay Therapeutics
unlisted
supplier
—
LEO Pharma
unlisted
customer
Shared
0
No disclosed counterparties: VYNE.
Only VYNE
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
YARW
Yarrow Bioscience, Inc.
Change
20.42
▲
+2.10%
· post 20.42
Mkt cap
$53.1M
Revenue
$97,000
Q2 FY26
Revenue
$501,000
FY24
VYNE
VYNE Therapeutics Inc.
Change
20.42
▲
+2.10%
· post 20.42
Closed
Oct 30 '26
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
YARW
Yarrow Bioscience, Inc.
vs
VYNE
VYNE Therapeutics Inc.
20.42
▲
+2.10%
post 20.42
Price
20.42
▲
+2.10%
post 20.42
$53.1M
Mkt cap
—
Q2 FY26
$97,000
Revenue
—
FY24
$501,000
Revenue
—
Change
Change
YARW
20.42
▲
+2.10%
vs
VYNE
20.42
▲
+2.10%
Closed
Oct 30 '26